In this talk, Dr. Cecilia Yeung from the Fred Hutchinson Cancer Research Center discusses her experience using Anchored Multiplex PCR (AMP™) technology to identify fusions in leukemias. Dr. Yeung and her team used Archer® FusionPlex® assays to sequence myeloid and Acute Lymphoma Leukemia (ALL) samples. They were able to successfully detect point mutations, small indels and expression data using the Archer Analysis bioinformatics platform. Additionally, Dr. Yeung used the RNA-based Archer assay in conjunction with a MinION® real-time sequencer (Oxford Nanopore Technologies) for rapid fusion detection. Watch the video to find out the results.
This video was recorded at the Cancer Genomics Consortium (CGC) annual meeting in August, 2018.
Utility of Anchored Multiplex PCR for gene fusion detection
2477 55th Street, Suite 202
Boulder, CO 80301